Literature DB >> 16622664

ANCA-associated diffuse alveolar hemorrhage due to benzylthiouracil.

Farah Thabet1, Rim Sghiri, Brahim Tabarki, Ibtissem Ghedira, Moncef Yacoub, Ahmed Sahloul Essoussi.   

Abstract

Benzylthiouracil has been recently observed to be associated with antineutrophil cytoplasmic antibody-positive vasculitis, resulting in crescentic glomerulonephritis. We report an 8-year-old girl treated with benzylthiouracil for Graves's disease who developed an ANCA-positive vasculitis with pulmonary hemorrhage. She responded to corticosteroids and discontinuation of benzylthiouracil. This represents the first pediatric case of benzylthiouracil-induced diffuse alveolar hemorrhage.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622664     DOI： 10.1007/s00431-005-0053-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  9 in total

1.  Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: report of the first case.

Authors:  Faiçal Jarraya; Mohamed Abid; Rachid Jlidi; Khaled Mkaouar; Mouna Mnif; Mahmoud Kharrat; Khaled Charfeddine; Khaoula Kammoun; Mohamed Ben Hmida; Jamil Hachicha
Journal:  Nephrol Dial Transplant       Date:  2003-11       Impact factor: 5.992

2.  [Benzylthiouracil induced ANCA-positive vasculitis].

Authors:  Amel Braham; Med Habib Houman; Lamia Rais; Imed Ben Gborbel; Mounir Lamloum; Mohamed Miled
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

3.  Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.

Authors:  X Jiang; G Khursigara; R L Rubin
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

Review 4.  [Vasculitis with renal and pulmonary involvement in a patient receiving benzylthiouracil for Graves disease].

Authors:  H Kaaroud; K Khiari; F Ben Moussa; S Barbouch; E Boussema; H Ben Maïz
Journal:  Rev Med Interne       Date:  2002-10       Impact factor: 0.728

5.  [ANCA associated glomerulonephritis related to benzylthiouracil].

Authors:  N Tieulie; Du Le Thi Huong; M Andreu; B Wechsler; L Mercadal; H Beaufils; M C Diermert; J C Piette
Journal:  Rev Med Interne       Date:  2002-10       Impact factor: 0.728

Review 6.  Diffuse alveolar hemorrhage syndromes.

Authors:  U Specks
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

Review 7.  Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'.

Authors:  G E Krassas
Journal:  Eur J Endocrinol       Date:  2004-04       Impact factor: 6.664

8.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.

Authors:  K M Dolman; R O Gans; T J Vervaat; G Zevenbergen; D Maingay; R E Nikkels; A J Donker; A E von dem Borne; R Goldschmeding
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

9.  Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.

Authors:  Preamrudee Poomthavorn; Pat Mahachoklertwattana; Wiwat Tapaneya-Olarn; Ampaiwan Chuansumrit; Amornsri Chunharas
Journal:  J Med Assoc Thai       Date:  2002-11
  9 in total
  1 in total

1.  Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review.

Authors:  Fatima Bensiradj; Mathilde Hignard; Rand Nakkash; Alice Proux; Nathalie Massy; Nadir Kadri; Jean Doucet; Isabelle Landrin
Journal:  Eur J Case Rep Intern Med       Date:  2019-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.